SCHEMBL4076437

SCHEMBL4076437

Nc1ccc(CO[PH](=O)O)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.46
CYP3A4 P08684 3/20 0.42
ALDH1A1 P00352 2/20 0.42
GFER P55789 1/20 0.42
TSHR P16473 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
MAOB P27338 7/20 0.41
LOXL2 Q9Y4K0 1/20 0.41
MAOA P21397 3/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CA3 P07451 1/20 0.39
THRB P10828 1/20 0.39
ALOX15 P16050 1/20 0.39
CA6 P23280 1/20 0.39
CASP1 P29466 1/20 0.39
HIF1A Q16665 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butane SCHEMBL9443644 0.92 APP (0.41) APPCYP3A4ALDH1A1GFERTSHR
Aniline SCHEMBL29187472 0.87 MAOB (0.50) ALDH1A1TSHRMAOBMAOAGAA
Aniline SCHEMBL29187471 0.87 MAOB (0.50) ALDH1A1TSHRMAOBMAOAGAA
SCHEMBL28119658 0.85 ABAT (0.48) MAOBLOXL2CA6CA14CA2
SCHEMBL22589820 0.84 IDO1 (0.48) APPALDH1A1TDP1L3MBTL1IDO1
SCHEMBL9849124 0.83 TAAR1 (0.54) ALDH1A1TSHRTDP1MAOBLOXL2
SCHEMBL17061043 0.83 CYP3A4 (0.50) APPCYP3A4IDO1
SCHEMBL3365610 0.83 PRSS1 (0.39) APPALDH1A1TSHRRAB9ASMN1; SMN2
SCHEMBL742829 0.82 ALDH1A1 (0.46) APPCYP3A4ALDH1A1GFERTSHR
SCHEMBL4055238 0.81 IDO1 (0.48) APPMAOBIDO1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118339172-A Phosphonic acid compounds and prodrugs thereof, preparation method and application thereof 上海海和药物研究开发股份有限公司 2024-07-12 CN disclosed
US-11801315-B2 Radioligands for myelin CASE WESTERN RESERVE UNIVERSITY (US) 2023-10-31 US disclosed
US-20230201382-A1 RADIOLIGANDS FOR MYELIN NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2023-06-29 US disclosed
EP-3426309-B1 RADIOLIGANDS FOR MYELIN UNIV CASE WESTERN RESERVE (US) 2022-05-04 EP disclosed
CN-113677350-A ENPP1 inhibitors and methods of modulating immune responses 里兰斯坦福初级大学理事会 2021-11-19 CN disclosed
US-20210128756-A1 RADIOLIGANDS FOR MYELIN NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2021-05-06 US disclosed
US-10765763-B2 Radioligands for myelin CASE WESTERN RESERVE UNIVERSITY (US) 2020-09-08 US disclosed
US-20190134232-A1 RADIOLIGANDS FOR MYELIN CASE WESTERN RESERVE UNIVERSITY 2019-05-09 US disclosed
EP-3426309-A1 RADIOLIGANDS FOR MYELIN Case Western Reserve University (US) 2019-01-16 EP disclosed
WO-2017156303-A1 RADIOLIGANDS FOR MYELIN CASE WESTERN RESERVE UNIVERSITY (US) 2017-09-14 WO disclosed
US-20050128562-A1 Nanoporous and nanocrystalline film and electrochromic device UNIVERSITY COLLEGE DUBLIN, A CONSTITUENT COLLEGE OF THE NATIONAL UNIVERSITY OF IRELAND 2005-06-16 US disclosed
US-20050128561-A1 Electrochromic compound UNIVERSITY COLLEGE DUBLIN, A CONSTITUENT COLLEGE OF THE NATIONAL UNIVERSITY OF IRELAND 2005-06-16 US disclosed
US-6870657-B1 Electrochromic device UNIVERSITY COLLEGE DUBLIN (IE) 2005-03-22 US disclosed
EP-1500969-A1 Compound and its use in electrochromic devices UNIVERSITY COLLEGE DUBLIN (IE) 2005-01-26 EP disclosed
EP-1224505-B1 ELECTROCHROMIC DEVICE UNIV DUBLIN (IE) 2005-01-12 EP disclosed
WO-2004100960-A2 ANTI-INFLAMMATORY PHOSPHONATE COMPOUNDS GILEAD SCIENCES, INC. (US) 2004-11-25 WO disclosed
WO-2004096236-A2 IMMUNOMODULATOR PHOSPHONATE CONJUGATES GILEAD SCIENCES, INC. (US) 2004-11-11 WO disclosed
EP-1224505-A1 ELECTROCHROMIC DEVICE UNIVERSITY COLLEGE DUBLIN (IE) 2002-07-24 EP disclosed
WO-2001027690-A2 ELECTROCHROMIC DEVICE UNIVERSITY COLLEGE DUBLIN (IE) 2001-04-19 WO disclosed
WO-1990008185-A1 MOLECULES WITH ANTIBODY COMBINING SITES THAT EXHIBIT STEREOSPECIFIC CATALYSIS SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) 1990-07-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190134232-A1 RADIOLIGANDS FOR MYELIN MAG, PMP22, MYT1 APP 1224/4885CYP3A4 4569/4885ALDH1A1 3084/4885
US-20230201382-A1 RADIOLIGANDS FOR MYELIN MAG, PMP22, MYT1 APP 1514/4885CYP3A4 2877/4885ALDH1A1 2144/4885
US-20210128756-A1 RADIOLIGANDS FOR MYELIN MAG, PMP22, MYT1 APP 1224/4885CYP3A4 4569/4885ALDH1A1 3084/4885
US-11801315-B2 Radioligands for myelin MAG, PMP22, MYT1 APP 1224/4885CYP3A4 4569/4885ALDH1A1 3084/4885
US-10765763-B2 Radioligands for myelin MAG, PMP22, MYT1 APP 1224/4885CYP3A4 4569/4885ALDH1A1 3084/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.